Is SSH a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

774 people get SSH articles and Market Currents by email alert.

Get email alerts on SSH »

HEADLINES:

Value Investors Take Note: Fire Sale On This Heart Failure Asset
PropThink • Mon, May 20 • 7 Comments
Johnson & Johnson: At The Crossroads - Part III
Robert Honeywill • Thu, May 16
Sunshine Heart Quietly Reports Breakthrough In Congestive Heart Failure Treatment
Logical Assessment • Wed, May 15 • 2 Comments
Sunshine Heart Announces Corporate Updates and First Quarter 2013 Financial Results

GlobeNewswire (May 14, 2013)
Johnson & Johnson: At The Crossroads - Part II
Robert Honeywill • Fri, May 10 • 1 Comment
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study

Marketwire (May 9, 2013)
Heartware Q1 Results: Good News For All LVAD Companies
Robert Honeywill • Fri, May 3
Sunshine Heart, Inc. Closes Public Offering of Common Shares

Marketwire (Apr 16, 2013)
Sunshine Heart: A 'Buy The Dips' Pick That Could Pay Off
VFC's Stock House • Mon, Apr 15 • 15 Comments
Stock Watch Thursday, 11 April 2013
VFC's Stock House • Thu, Apr 11 • 8 Comments
Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares

Marketwire (Apr 11, 2013)
Sunshine Heart, Inc. Announces Proposed Public Offering of Common Shares

Marketwire (Apr 10, 2013)
Weekly Stock Watch, Week Of 8 April 2013
VFC's Stock House • Mon, Apr 8 • 2 Comments
Medtronic And Sunshine Heart: Pacemaking And Counter-Pulsation - A Tale Of 2 Technologies
Robert Honeywill • Thu, Apr 4
Heartware's Public Offering: Takeover Bid For Sunshine Heart?
Robert Honeywill • Thu, Mar 21 • 3 Comments
Sunshine Heart Appoints Jon Salveson to Board of Directors

Marketwire (Mar 13, 2013)
3 Med Device Stocks Looking Very Attractive
Brian L. Wilson • Tue, Mar 12 • 5 Comments
Sunshine Heart Reports Fourth Quarter and Full Year 2012 Results

Marketwire (Mar 11, 2013)
HeartWare Is Premium-Priced Growth, But Could Still Go Higher
Stephen Simpson • Thu, Mar 7 • 8 Comments
Sunshine Heart: Potential '10 Bagger' In 4 Years, '100 Bagger' In 10 Years
Robert Honeywill • Thu, Mar 7 • 33 Comments

Risky Sunshine Heart Looks Very Interesting
Stephen Simpson • Thu, Feb 21 • 15 Comments

Value Investors Take Note: Fire Sale On This Heart Failure Asset
PropThink • Mon, May 20 • 7 Comments
Sunshine Heart Quietly Reports Breakthrough In Congestive Heart Failure Treatment
Logical Assessment • Wed, May 15 • 2 Comments
Sunshine Heart: A 'Buy The Dips' Pick That Could Pay Off
VFC's Stock House • Mon, Apr 15 • 15 Comments
Medtronic And Sunshine Heart: Pacemaking And Counter-Pulsation - A Tale Of 2 Technologies
Robert Honeywill • Thu, Apr 4
Sunshine Heart: Potential '10 Bagger' In 4 Years, '100 Bagger' In 10 Years
Robert Honeywill • Thu, Mar 7 • 33 Comments
Sunshine Heart: Risk And Reward
Robert Honeywill • Tue, Feb 26 • 31 Comments
Risky Sunshine Heart Looks Very Interesting
Stephen Simpson • Thu, Feb 21 • 15 Comments
Sunshine Heart: When Drugs Don't Work And LVADs Are Too Risky
Robert Honeywill • Mon, Jan 14 • 16 Comments
Is Sunshine The Solution To Device Tax Blues?
Logical Assessment • Tue, Dec 11, 2012 • 4 Comments
Sunshine Heart: A Takeover Bid Just A Heartbeat Away?
Biotech Breakthroughs • Thu, Nov 29, 2012 • 18 Comments
The $5 Billion Opportunity For Sunshine Heart's C-Pulse Device
Adam Sans • Fri, Nov 2, 2012 • 2 Comments
Not Enough Cash For Sunshine Heart
Alberto Savrieno • Tue, Oct 16, 2012 • 15 Comments
FDA Gives The 'OK' In Biggest News For This Medical Device Company To Date
LastFinancier • Mon, Oct 1, 2012 • 23 Comments
Sunshine Heart Moving On Positive Analyst Coverage And Pending Catalysts
VFC's Stock House • Wed, Sep 19, 2012 • 8 Comments
A $7 Medical Device Stock Analysts Think Will Double
Bret Jensen • Sun, Sep 9, 2012 • 25 Comments
Sunshine Heart - A Ground Floor Opportunity With Billion-Dollar Potential
VFC's Stock House • Wed, Aug 29, 2012 • 2 Comments
Sunshine Heart Gaps Higher On Another Round Of Milestone News
VFC's Stock House • Mon, Aug 6, 2012
Sunshine Heart Soars On Milestone Approval News
VFC's Stock House • Wed, Jul 25, 2012 • 2 Comments
Sunshine Heart's Pullback Offers Investors A Second Chance
VFC's Stock House • Wed, Jul 18, 2012 • 5 Comments

Johnson & Johnson: At The Crossroads - Part III
Robert Honeywill • Thu, May 16
Johnson & Johnson: At The Crossroads - Part II
Robert Honeywill • Fri, May 10 • 1 Comment
Heartware Q1 Results: Good News For All LVAD Companies
Robert Honeywill • Fri, May 3
Stock Watch Thursday, 11 April 2013
VFC's Stock House • Thu, Apr 11 • 8 Comments
Weekly Stock Watch, Week Of 8 April 2013
VFC's Stock House • Mon, Apr 8 • 2 Comments
Heartware's Public Offering: Takeover Bid For Sunshine Heart?
Robert Honeywill • Thu, Mar 21 • 3 Comments
3 Med Device Stocks Looking Very Attractive
Brian L. Wilson • Tue, Mar 12 • 5 Comments
HeartWare Is Premium-Priced Growth, But Could Still Go Higher
Stephen Simpson • Thu, Mar 7 • 8 Comments
Stock Watch Wednesday, 6 February 2013
VFC's Stock House • Wed, Feb 6 • 5 Comments
Stock Watch Thursday, 31 January 2013
VFC's Stock House • Thu, Jan 31 • 1 Comment
Stock Watch Wednesday, 21 November
VFC's Stock House • Wed, Nov 21, 2012 • 2 Comments
Weekly Stock Watch, Week Of 12 November
VFC's Stock House • Mon, Nov 12, 2012 • 2 Comments
Analyst Scott Power Finds The Upside In Biotech Down Under
Life Sciences Report • Thu, Nov 8, 2012
Heart Failure: 'New Epidemic' Creates New Opportunities For Investors
Cris Frangold • Sun, Nov 4, 2012 • 2 Comments
Mid-Week Stock Watch, Week Of 29 October
VFC's Stock House • Thu, Nov 1, 2012 • 2 Comments
Weekly Stock Watch For October 22, 2012
VFC's Stock House • Mon, Oct 22, 2012 • 4 Comments
The Figure-4 Dead Fall Trap And 4-Biotechnology Recommendations For October
Michael Webb • Thu, Oct 18, 2012 • 24 Comments
6 Stocks On The Move This Week
VFC's Stock House • Fri, Oct 5, 2012 • 2 Comments
4 Share Price Dips That Might Only Be Temporary
VFC's Stock House • Fri, Sep 28, 2012 • 1 Comment
Weekly Stock Watch: Week Of 4 September
VFC's Stock House • Tue, Sep 4, 2012 • 6 Comments

There are no Transcripts on SSH.

Sunshine Heart Announces Corporate Updates and First Quarter 2013 Financial Results

GlobeNewswire (May 14, 2013)
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study

Marketwire (May 9, 2013)
Sunshine Heart, Inc. Closes Public Offering of Common Shares

Marketwire (Apr 16, 2013)
Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares

Marketwire (Apr 11, 2013)
Sunshine Heart, Inc. Announces Proposed Public Offering of Common Shares

Marketwire (Apr 10, 2013)
Sunshine Heart Appoints Jon Salveson to Board of Directors

Marketwire (Mar 13, 2013)
Sunshine Heart Reports Fourth Quarter and Full Year 2012 Results

Marketwire (Mar 11, 2013)
Sunshine Heart to Attend Upcoming Investor Conferences

Marketwire (Feb 26, 2013)
Sunshine Heart Appoints Warren Watson to Board of Directors

Marketwire (Jan 30, 2013)
Sunshine Heart to Delist From the Australian Securities Exchange

Marketwire (Jan 29, 2013)
Sunshine Heart Enters Into a $25 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

Marketwire (Jan 15, 2013)
Sunshine Heart Provides Clinical Update

Marketwire (Jan 7, 2013)
Sunshine Heart Receives Unconditional FDA Approval for C-Pulse(R) System's U.S. Pivotal Trial

Marketwire (Nov 20, 2012)
Sunshine Heart Announces 3Q12 Financial Results

Marketwire (Nov 8, 2012)
Sunshine Heart to Present at Upcoming Investor Conferences

Marketwire (Nov 8, 2012)
Sunshine Heart Receives 2012 Frost & Sullivan North American Heart Failure Treatment New Product Innovation Award for C-Pulse(R)

Marketwire (Oct 23, 2012)
Sunshine Heart's Feasibility Study Data to Be Presented at 2012 Transcatheter Cardiovascular Therapeutics Conference

Marketwire (Oct 18, 2012)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Oct 1, 2012)
Sunshine Heart Announces Conditional Approval of IDE From the FDA for C-Pulse(R) Heart Assist System

Marketwire (Oct 1, 2012)
Sunshine Heart Appoints John Erb to Chairman of the Board

Marketwire (Sep 13, 2012)

SSH vs. ETF Alternatives

Company Description

Currently, there's no company description for SSH.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 14, 11:27 AM Sunshine Heart (SSH +5.5%) moves up after reporting a Q1 net loss of $4.4M, or $0.47 per share, compared to a loss of $4.1M or $0.66 per share in Q112, and beating Street estimates for a loss of $0.51. The company ended the quarter with $11M in cash, compared to $14.2 million at the end of FY12. Looking forward, the company says it's currently in discussions with physicians regarding the potential weaning of additional patients from its C-Pulse system study, based upon significant improvements since the time of implant. Comment! [Global & FX, Healthcare, On the Move]
Thursday, April 11, 3:44 PM Shares of Sunshine Heart (SSH -11.3%) slide today after pricing its offer of 2.5M shares at $5.25 per share, a 13% discount to Wednesday's close. The medical-device maker plans to use the proceeds for clinical trials and product development, as well as other general purposes. The company has a current float of around 9.5M shares. 1 Comment [Global & FX, Healthcare, On the Move]
Wednesday, April 10, 4:51 PM Sunshine Heart (SSH) announces a public offering of its common stock, with a 30-day underwriter-option to purchase up to an additional 15% for overallotments. The size and terms of the offering were not disclosed. Net proceeds will be used for general corporate purposes, including its ongoing clinical trial and product development activities. Shares -5% AH. Comment! [Global & FX, On the Move]
Monday, March 11, 6:42 AM Sunshine Heart (SSH):Q4 EPS of -$0.45 beats by $0.04. (PR) Comment! [Earnings, Breaking News]
Tuesday, November 20, 2012, 8:34 AM Sunshine Heart (SSH +17.45%) shines brightly after it receives unconditional approval from the FDA for a U.S. trial for its flagship C-Pulse Heart Assist System. The company expects to generate revenues from the study, which is due to start this quarter, as the FDA has granted C-Pulse CMS Category B3 status. This means trial centers will probably be reimbursed by CMS and most insurance providers. (PR) 1 Comment [On the Move, Healthcare]
Monday, October 1, 2012, 8:17 AM Sunshine Heart (SSH) up 19% premarket as it gets conditional FDA approval to move into a Q4 trial for its C-Pulse Heart Assist System. A 388-patient trial will see half being implanted with the system as part of a series of "timely approvals," SSH says. Comment! [Healthcare, On the Move]
Friday, August 10, 2012, 11:07 AM Sunshine Heart (SSH -16.2%) gets slammed today after initially announcing a 2.5M share secondary offering , then boosting the size of the offering to just under 2.9M shares and pricing it at $7, a 15% discount to Thursday's close. The offering will bring in around $20M, which will likely be put to use in bringing to market its next-generation C-Pulse Driver, which received conditional FDA approval earlier this week. 2 Comments [Healthcare, Global & FX, On the Move]
Monday, August 6, 2012, 9:12 AM Sunshine Heart (SSH) +17.3% premarket after the company says it received conditional FDA approval for its next-generation C-Pulse Driver, a device designed to provide moderate to severe heart failure patients with enhanced patient comfort and performance. 1 Comment [Healthcare, On the Move]
Wednesday, July 25, 2012, 9:53 AM Sunshine Heart (SSH +23.5%) says it has received CE Mark approval for its C-Pulse Heart Assist System for the treatment of heart failure, which will allow for the commercialization of the technology in Europe and countries in Asia and Latin America that recognize the CE Mark. SSH estimates 3.7M potential patients for the device in the EU. Comment! [Healthcare, On the Move]
Monday, July 23, 2012, 11:45 AM Shares of Sunshine Heart (SSH +18%) jump this morning after announcing it's completed a two-year follow-up for a feasibility trial involving a patient that was implanted with its C-Pulse Heart Assist System. This was the first patient to reach two-year follow-up in the trial, which showed no neurological events and a statistically significant improvement in the patient's quality of life. Comment! [Healthcare, On the Move]

VFC's Stock House
Don't let these five speculative plays slip below the radar ... $FPMI.OB, $SSH, $ANTB.OB, $APHY.OB, $TTNP.OB ... http://bit.ly/cAHZ42
Apr 25, 8:05 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
$SSH - A 'buy the dips' play that could pay off big - pullback from offering could be nice buy ... http://bit.ly/cAHZ42
Apr 14, 12:15 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
$SSH - as trial progresses, today's prices could end up a bargain ... http://bit.ly/150y3w9
Apr 11, 11:47 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
$SSH, $INO, $APHY.OB Stock Watch Wednesday, http://bit.ly/cAHZ42 - $SNWV.OB, $ANTB.OB, $TTNP.OB
Apr 11, 8:56 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
$SNWV.OB, $FPMI.OB, $SSH, $HTWR, $THOR- Weekly Stock Watch, Focus Medical Devices and Developmental healthcare ... http://bit.ly/cAHZ42
Apr 8, 5:40 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Webb
$SSH Jon W. Salveson on Board of Directors from Piper J. Has "extensive corporate transaction experience." Hmm, why would we need that?
Mar 14, 2:03 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Webb
$SSH Sunshine Heart is poised for a huge run upward with a double bottom reversal pattern three days from completion.
Mar 2, 4:50 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Webb
$SSH This is a buy and hold for 4 years. Win at 12 times current price or lose it all. I'm in!
Feb 15, 5:53 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
$SSH. Rollin'. Nice. http://seekingalpha.com/a/okfr
Feb 5, 1:39 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

VFC's Stock House
Weekly Stock Watch: $GE, $MCD, $IMSC.PK, $SSH, $F, $BBRY, $SGYP, $IRWD, $WMT, $BA, $GOOG - http://bit.ly/TYNiux
11/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

VFC's Stock House
Turkey Day Stock Watch: $SSH, $HP, $BBY, $FB, $GOOG, $MSFT, $AMRN, $YHOO http://bit.ly/10tah6Z
11/21/12
Reply (1)

• !Report Abuse
View all 1 replies
William LeGro: Wow! AMRN now has 8,314,086 patents for Vascepa! Be still my heart! "Sunshine keeps fallin' on my head..."
11/21/12
• !Report Abuse
Add a reply...

140 characters

VFC's Stock House
$SSH - Sunshine's dip may be unjustified and temporary - http://bit.ly/WtLGj4
10/18/12
Reply (1)

• !Report Abuse
View all 1 replies
Hoang6: How about SGYP?
10/18/12
• !Report Abuse
Add a reply...

140 characters

VFC's Stock House
$AMRN, $SSH, $NBS, $AEZS, $SIRI, $FCEL - Mid-Week Movers - http://bit.ly/QvWec9
10/4/12
Reply (1)

• !Report Abuse
View all 1 replies
wiesemc: Do you advise waiting until the AEZS split or purchase now?
10/4/12
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Looks like someone is manipulating Sunshine Heart's (SSH) stock. It will likely go up then quickly come down. http://yhoo.it/U5uMBL
9/10/12
Reply (3)

• !Report Abuse
View all 3 replies
Michael Webb: Or it got the Bret Jensen bump with his article: "A $7 Medical Device Stock Analysts Think Will Double" written the day before.
9/11/12
• !Report Abuse
Michael Bryant: History will repeat itself.
9/11/12
• !Report Abuse
Add a reply...

140 characters

SSH Sunshine Heart, Inc.

SSH

Sunshine Heart, Inc.